CLINICAL TRIAL AGREEMENT ZMLUVA O KLINICKOM SKÚŠANÍClinical Trial Agreement Zmluva O Klinickom Skúšaní • November 13th, 2014
• Quintiles Slovakia, s. r. o. having a place of business at Zamocka 34, 811 01 Bratislava, Slovak Republic, Organisation No: 45942269, Filed in the Companies register of the District Court Bratislava I, section: Sro, File no: 69023/B represented by: Aurelia Mojzesova, MD Power of attorney issued on 30.4.2013 (“Quintiles”),
ContractClinical Trial Agreement Zmluva O Klinickom Skúšaní • December 11th, 2023
CLINICAL TRIAL AGREEMENT ZMLUVA O KLINICKOM SKÚŠANÍ This Clinical Trial Agreement (“Agreement”), which shall become effective on the day after its publication in the Register of Contracts OR as of the last signature date below (“Effective Date”), is by and between: Táto zmluva o klinickom skúšaní (ďalej len„zmluva“), ktorá nadobúda účinnosť dňom po jej zverejnení v registri zmlúv ALEBO k dátumu posledného podpisu nižšie (ďalej len „dátum nadobudnutia účinnosti“), sa uzatvára medzi: Telavant, Inc., a Delaware corporation, file number 7132956, with its principal place of business at 151 W 42nd Street, Floor 15, New York, NY 10036(“Sponsor”), spoločnosťou Telavant, Inc., registrovanou ve state Delaware, ICO 7132956, so sídlom na adrese 151 W 42nd Street, Floor 15, New York, NY 10036(ďalej len „zadávateľ“), Faculty hospital with polyclinic of F. D. Roosevelt Banská Bystrica with headquarters at Nám. L. Svobodu 1, Banská Bystrica 975 17, SlovakRepublic, IČO: 00165549, DIČ: 2021095670, IČDPH
ContractClinical Trial Agreement Zmluva O Klinickom Skúšaní • December 16th, 2021
CLINICAL TRIAL AGREEMENT ZMLUVA O KLINICKOM SKÚŠANÍ The Clinical Trial Agreement (“Agreement”) is made by and between: Dagmar Sudekova MD, having a place of business at Fakultna nemocnica s poliklinikou Zilina, Oddelenie klinickej a radiacnej onkologie, Ul. Vojtecha Spanyola 43, 012 07 Zilina, Slovak Republic (the “Investigator”) and Fakultna nemocnica s poliklinikou Zilina Ul. Vojtecha Spanyola 43, 012 07 Zilina Slovak RepublicRepresented by: Mgr. Eduard Dorcik, Director Organisation Identification No.: 17335825 Tax Identification No.: 2020699923VAT ID: SK2020699923Bank Co-ordinates:Account No.:SWIFT: SPSRSKBA IBAN:(the “Institution”) andG1 Therapeutics, Inc. with a registerred seat at 700 PARK OFFICES DRIVE SUITE 200 RESEARCH TRIANGLE PARK NC 27709, UnitedStates of America, the company is registered in: DELAWARE, ID No: 001-38096, Tax ID: 26- 3648180 (hereinafter referred to as the “Sponsor”) Represented by:IQVIA RDS Slovakia, s.r.o. having a place of business at Vajnorská 100/B, 831
ContractClinical Trial Agreement Zmluva O Klinickom Skúšaní • April 8th, 2022
CLINICAL TRIAL AGREEMENT ZMLUVA O KLINICKOM SKÚŠANÍ This Clinical Trial Agreement (the “Agreement”) is by and between Arcus Biosciences, Inc., a Delaware corporation, with its principal place of business at 3928 Point Eden Way, Hayward, CA 94545, (“Sponsor”), as represented by its affiliate, Arcus Biosciences Europe Limited, domiciled at 88 Harcourt Street, Dublin 2, D02 DK18, Ireland (“EU Legal Representative”), and Túto zmluvu o klinickom skúšaní (ďalej „zmluva“) uzatvárajú k spoločnosť Arcus Biosciences, Inc., registrovaná v štáte Delaware, so sídlom na adrese 3928 Point Eden Way, Hayward, CA 94545, (ďalej„zadávateľ“), zastúpená svojou dcérskou spoločnosťou Arcus Biosciences Europe Limited, so sídlom na adrese 88 Harcourt Street, Dublin 2, D02 DK18, Írsko (ďalej „právny zástupca v EÚ“), a Vychodoslovensky onkologicky ustav, a.s. Rastislavova 43, 041 91 Kosice, Slovak Republic (“Institution”). Sponsor and Institution shall collectively be referred to as “Parties.” Vychodoslovenský on
ContractClinical Trial Agreement Zmluva O Klinickom Skúšaní • February 26th, 2021
CLINICAL TRIAL AGREEMENT ZMLUVA O KLINICKOM SKÚŠANÍ This Clinical Trial Agreement (“Agreement”), effective as of the date of last signature (“Effective Date”), is entered into between Regeneron Pharmaceuticals, Inc.,having an address at 777 Old Saw Mill River Road, Tarrytown, NY 10591 United States (“Sponsor”), Národný ústav detských chorôb (NÚDCH),having an address at Limbová 1833 40 Bratislava, SlovakiaIČO: 00607231DIČ: 2020848368IČ DPH: SK2020848368Represented by Ing. et Ing. Peter Magát,Director(“Institution”) and ,Date of birth:having an address at , Slovakia(“Principal Investigator”). Túto zmluvu o klinickom skúšaní (ďalej len „zmluva“), účinnú od dátumu posledného podpisu (ďalej len „dátum účinnosti“) uzatvárajú spoločnosť Regeneron Pharmaceuticals, Inc.,so sídlom na 777 Old Saw Mill River Road, Tarrytown, NY 10591 Spojené štáty americké (ďalej len „zadávateľ“), Národný ústav detských chorôb (NÚDCH),so sídlom Limbová 1833 40 Bratislava, SlovakiaIČO: 00607231DIČ: 2020848368IČ DPH
CLINICAL TRIAL AGREEMENT ZMLUVA O KLINICKOM SKÚŠANÍClinical Trial Agreement Zmluva O Klinickom Skúšaní • July 2nd, 2021
Fakultna nemocnica s poliklinikou F.D. Roosevelta Banska Bystrica, having a place of business at Namestie L. Svobodu 1, 975 17 Banska Bystrica, Slovak Republic, Organisation No: 00165549, Tax Identification No. 2021095670 (the “Institution”) represented by Ing. Miriam Lapuníková, MBA, the managing director and Milan Urbani, MPH, MD, the medical director (the “Institution”),
CLINICAL TRIAL AGREEMENT ZMLUVA O KLINICKOM SKÚŠANÍClinical Trial Agreement Zmluva O Klinickom Skúšaní • September 27th, 2016
Quintiles Eastern Holdings GmbH having a place of business at Stella-Klein-Lôw-Weg 15, Rund 4, Haus B, OG 4, 1020 Vienna, Austria ("Quintiles"),
